TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CGON

CG Oncology, Inc.

Healthcare · Biotechnology

77.70$ -0.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGON
Line item 2021 2022 2023 2024 2025
+50.0% +13.3% +88.2% +4,415.6%
-39.2% +126.0% +646.2% +134.0%
-22.5% -15.5% -21.7%
-85.6% -100.0% -42.7%
+56,963.9% +119.0% +148.2% -18.3%
-100.0% -97.8% -100.0%
+674.9% -27.3% +622.2% -75.6%
+1,937.5% -331.3% -190.3%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?